Neuronetics (STIM) Revenue (2017 - 2026)

Neuronetics (STIM) has 10 years of Revenue data on file, last reported at $34.5 million in Q1 2026.

• On a quarterly basis, Revenue rose 7.75% year-over-year to $34.5 million in Q1 2026; TTM through Mar 2026 was $151.6 million, a 69.52% increase from a year earlier, with the FY2025 full-year figure at $149.2 million, up 99.17% from the prior year.
• Revenue for Q1 2026 stood at $34.5 million, down from $41.8 million in the prior quarter.
• Over the last five years, Revenue for STIM reached as high as $41.8 million in Q4 2025 and fell as low as $14.2 million in Q1 2022.
• Historically, Revenue has averaged $23.2 million across 5 years, with a median of $18.2 million in 2022.
• Across the five-year window, Revenue declined 6.59% in 2024 and surged 131.66% in 2025, its largest moves.
• Year by year, Revenue stood at $18.2 million in 2022, then gained by 11.63% to $20.3 million in 2023, then climbed by 10.73% to $22.5 million in 2024, then surged by 85.73% to $41.8 million in 2025, then fell by 17.53% to $34.5 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $34.5 million in Q1 2026, $41.8 million in Q4 2025, and $37.3 million in Q3 2025.